Alkahest, Inc. has appointed Robert Klein, Ph.D. as chief business officer. Robert Klein is a business development professional with over two decades of experience in the biotechnology, diagnostics and genomics spaces. He has spent half his career working in neuroscience drug development as both a scientist and a business development professional.    Robert joins Alkahest after having served as chief business officer at Complete Genomics and having held positions of chief executive officer at ...